Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mast cell-derived IL-10 protects intestinal barrier integrity during malaria in mice and regulates parasite transmission to Anopheles stephensi with a female-biased immune response.
Céspedes N, Donnelly EL, Hansten G, Fellows AM, Dobson M, Kaylor HL, Coles TA, Schauer J, Van de Water J, Luckhart S. Céspedes N, et al. Among authors: fellows am. Infect Immun. 2024 Mar 12;92(3):e0036023. doi: 10.1128/iai.00360-23. Epub 2024 Feb 1. Infect Immun. 2024. PMID: 38299826
Electrified/charged aqueous interfaces: general discussion.
Advincula XR, Backus EHG, Bonn M, Cox SJ, Diebold U, Fellows A, Finney AR, Goel G, Hedley J, Jiang Y, Jin D, Kapil V, Kavokine N, Klein J, Laage D, Mohandas N, Morgenstern K, Mukherjee T, Olvera de la Cruz M, Orlikowska-Rzeznik H, Perkin S, Piaggi PM, Rodellar CG, Ryan P, Sayer T, Seyffertitz M, Shepelenko M, Sosso GC, Thämer M, Vilangottunjalil A, Walker-Gibbons R, Wang Y, Willard AP, Zhang P. Advincula XR, et al. Among authors: fellows a. Faraday Discuss. 2024 Feb 6;249(0):381-407. doi: 10.1039/d3fd90065g. Faraday Discuss. 2024. PMID: 38170868 No abstract available.
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Ford AC, Wright-Hughes A, Alderson SL, Ow PL, Ridd MJ, Foy R, Bianco G, Bishop FL, Chaddock M, Cook H, Cooper D, Fernandez C, Guthrie EA, Hartley S, Herbert A, Howdon D, Muir DP, Nath T, Newman S, Smith T, Taylor CA, Teasdale EJ, Thornton R, Farrin AJ, Everitt HA; ATLANTIS trialists. Ford AC, et al. Lancet. 2023 Nov 11;402(10414):1773-1785. doi: 10.1016/S0140-6736(23)01523-4. Epub 2023 Oct 16. Lancet. 2023. PMID: 37858323 Free article. Clinical Trial.
135 results